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Abstract
Background: Despite the high prevalence of mood problems after stroke, evidence on effective interventions
particularly for those with aphasia is limited. There is a pressing need to systematically evaluate interventions
aiming to improve wellbeing for people with stroke and aphasia. This study aims to evaluate the feasibility of a
peer-befriending intervention.
Methods/design: SUPERB is a single blind, parallel group feasibility trial of peer befriending for people with aphasia
post-stroke and low levels of psychological distress. The trial includes a nested qualitative study and pilot economic
evaluation and it compares usual care (n = 30) with usual care + peer befriending (n = 30). Feasibility outcomes include
proportion screened who meet criteria, proportion who consent, rate of consent, number of missing/incomplete data
on outcome measures, attrition rate at follow-up, potential value of conducting main trial using value of information
analysis (economic evaluation), description of usual care, and treatment fidelity of peer befriending. Assessments and
outcome measures (mood, wellbeing, communication, and social participation) for participants and significant others
will be administered at baseline, with outcome measures re-administered at 4 and 10months post-randomisation. Peer
befrienders will complete outcome measures before training and after they have completed two cycles of befriending.
The qualitative study will use semi-structured interviews of purposively sampled participants (n = 20) and significant
others (n = 10) from both arms of the trial, and all peer befrienders to explore the acceptability of procedures and
experiences of care. The pilot economic evaluation will utilise the European Quality of life measure (EQ-5D-5 L) and a
stroke-adapted version of the Client Service Receipt Inventory (CSRI).
Discussion: This study will provide information on feasibility outcomes and an initial indication of whether peer
befriending is a suitable intervention to explore further in a definitive phase III randomised controlled trial.
Trial registration: ClinicalTrials.gov identifier NCT02947776, registered 28th October 2016.
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Background
Stroke and aphasia can have a profound impact on peo-
ple’s lives. Depression is a common sequel of stroke,
with rates remaining high even 1 year later at 33% [1].
Depression is associated with worse rehabilitation out-
comes, increased carer strain, increased healthcare util-
isation, and higher mortality [2–4]. Yet, the Stroke
Association’s report ‘Feeling overwhelmed’ [5] highlights
that over half of stroke units in England still have no ac-
cess to psychology services; and that two thirds of stroke
survivors felt their emotional needs were not as well
looked after as their physical needs.
There is evidence that the psychological needs of
people with aphasia are even greater than in the general
stroke population. One study reported a 62% rate of de-
pression in this group 1 year post-stroke [6] and family
of people with aphasia post-stroke often fall under strain
[7]. Social support and social networks are also affected
[8]. People with aphasia take part in fewer social activ-
ities [9] and are at risk of losing contact with friends and
their wider social network [10, 11]. This is particularly
concerning, as poor social support is associated with
worse physical recovery [12] and increased likelihood of
a future adverse event such as a second stroke [13]. It is
therefore paramount to support psychosocial well-being
post stroke and aphasia.
A UK audit of clinical psychology services for people
with mood problems post-stroke across ten stroke ser-
vices found that the most common outcome of mood
assessment was monitoring and advice, with less than
half of patients identified as having low mood receiving
psychological intervention [14]. The National Clinical
Guideline for Stroke [15] highlights that psychological
care after stroke should be multifaceted, involving many
agencies—health, social care, voluntary. It recommends
that services for people with stroke should offer psycho-
logical support to all patients regardless of whether they
exhibit specific mental health or cognitive difficulties
and use a matched care model to select the level of sup-
port appropriate to the person’s needs. A Cochrane sys-
tematic review on the effectiveness of psychological
therapies for treating post-stroke depression identified
that most studies excluded people with aphasia [16].
There is a pressing need to systematically evaluate inter-
ventions that aim to improve psychosocial wellbeing for
people with stroke and for the vulnerable group of
people with aphasia in particular.
The proposed study aims to address this need for
people with aphasia with no or low levels of psycho-
logical distress. A systematic review of rehabilitation in-
terventions to prevent and treat depression specifically
in post-stroke aphasia found that though some interven-
tions may enhance mood for those without clinically sig-
nificant depression, they do not lead to significant
reductions in depression scores [17]. Evidence of benefit
for those with no or low mood problems would be par-
ticularly welcome, as these interventions might help to
avert some of the long-term psychological consequences
of stroke and prevent the need for more complex and
possibly more costly psychological therapies.
An intervention with potential for application in the
field of stroke and aphasia is one to one peer support/
peer befriending. Peer befriending is widely used in men-
tal health [18] and other long-term conditions [19]. Peer
befriending is social and emotional support provided by
people with experience of a condition to others sharing
a similar condition to bring about a desired social or
personal change [20]. Peer befriending has been evalu-
ated in stroke but only within a hospital setting and not
for those with aphasia [21]. Peer befrienders, who have
achieved improvements in their own condition, have
been found to offer acceptance, respect, empathy, sup-
port, companionship, and hope and share experiences
and ideas about how to cope [22]. A recent systematic
review and meta-analysis found moderate but significant
positive effects of befriending on depressive symptoms
in depressed elderly people [standard difference in
means SMD = − 0.75] [23].
In the UK, a charity for people with aphasia (formerly
Connect—the communication disability network, now
Re-Connect) offers a peer-befriending scheme. The
scheme has mostly targeted those with aphasia in the
longer term post-stroke who are socially isolated with
poor access to support systems. Positive outcomes have
been reported for people with aphasia taking part in the
befriending scheme, their families, and health profes-
sionals involved in their care [24]. The current study
aims to answer feasibility questions about a refined ver-
sion of the peer befriending scheme that is offered to
people with aphasia post-stroke earlier, i.e. when they
are discharged to the community from hospital, active
care is withdrawn, and they have an increased need for
support [25].
Objectives
This study aims to provide answers to questions about
the feasibility of a definitive phase III randomised con-
trolled trial (RCT) of the clinical and cost-effectiveness
of peer befriending for people with aphasia post-stroke.
These questions include the following:
 Feasibility of recruitment and retention to the trial
 Acceptability of research procedures and outcome
measures
 Acceptability of usual care + peer befriending
compared with usual care control to (a) participants,
(b) their significant others, and (c) peer befrienders
 Documentation of usual care
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 Treatment fidelity of peer befriending
 Exploration of psychological and social well-being
outcomes as outcomes for a definitive trial for (a)
people with aphasia receiving usual care + peer
befriending versus usual care control, (b) their
significant others, and (c) peer befrienders
 Feasibility of a full economic evaluation of usual care
+ peer befriending versus usual care control.
Methods/design
The study is a single-blind, mixed methods, parallel group
pilot feasibility (phase II) multicentre RCT comparing
usual care with usual care + peer befriending for people
with aphasia post-stroke and low levels of psychological
distress. To ensure all necessary aspects were addressed in
the study protocol, the Standard Protocol Items: Recom-
mendations for Interventional Trials (SPIRIT) checklist
[26, 27] was adhered to and the Template for Intervention
Description and Replication (TIDieR) [28] was used (see
Additional files 1 and 2). SPIRIT checklist page numbers
refer to the full study protocol (see Additional file 3).
Participants
Setting
This study takes place in North London boroughs. Pri-
mary recruitment sites are hospitals. To maximise recruit-
ment and pick up in the community people who may have
been missed in the hospital, we also recruited from com-
munity services (e.g. Speech and Language Therapy (SLT)
teams), and in the second half of the recruitment period,
we also recruited from GP practices within the included
boroughs. The hospital sites and GP practices were re-
cruited through the North Thames National Institute for
Health Research (NIHR) Clinical Research Network
(CRN), which has adopted the study into their portfolio,
and through the study team’s SLT contacts with services.
Hospital sites were excluded if they have active commu-
nity peer befriending schemes for people with aphasia in
place. Baseline assessments and randomisation take place
when participants with aphasia are back in the community
and, where applicable, have completed intensive rehabili-
tation care (early supported discharge). For this reason,
community SLT services were asked to identify people
who had just completed or were close to competing inten-
sive input. GP practices were asked to identify people who
had a stroke up to 6 months previously.
Participants with aphasia
Inclusion criteria for participants with aphasia are as
follows:
 Over 18 years of age.
 Fluent premorbid users of English (confirmed by
relative or self-report).
 Presence of aphasia due to stroke: determined by the
multidisciplinary team notes, based on SLT
diagnosis. In cases of uncertainty, i.e. where there is
no SLT diagnosis at the time of recruiting to the
trial, CRN nurses will use the Frenchay Aphasia
Screening Test [29] for screening for aphasia. In
these cases, the presence of aphasia will be
determined based on the published cut-offs in the
Frenchay Aphasia Screening Test manual.
 Low levels of emotional distress. This aims to ensure
that participants do not require more complex
psychological interventions. To determine the level
of emotional distress, the Depression Intensity Scale
Circles (DISCS) [30] will be used. This tool is
recommended for people with communication
problems, cognitive deficits, and visual perception
problems post-stroke [31]. Scores on DISCS range
0–5, with a score of 0–1 indicating no/low distress
and a score of ≥ 2 used as a cut-off for identifying
depression in those with complex disabilities following
brain injury [30]. Those scoring 0–1 will be eligible for
the study. If a participant scores ≥ 2 on DISCS, they
will be referred back to the multidisciplinary team for
consideration for more complex psychological care as
appropriate. People who score 2 (which is also the
median on DISCS) and who the multidisciplinary
team deems do not need other psychological care or
other psychological care is not available will still be
eligible to take part. If a person scores 3 if screened
while still in the hospital, and is uncertain about their
level of emotional distress or feels they will be better
once home, consent will be obtained to re-screen
them for eligibility when they return to the community
(second screen). If at the second screen they score 0–1,
or 2 as described above, then they will be eligible to take
part.
Significant others
Each person with aphasia will be invited to nominate
one significant other, who is their closest confidant and
who is over 18 years of age. If participants live alone,
their significant other should be someone that they see
at least once a week. Consent will be sought from sig-
nificant others to take part in the study. If a significant
other does not meet eligibility criteria or does not give
consent to take part, we will approach up to three alter-
native individuals nominated by the person with aphasia.
People with aphasia without a significant other or whose
significant other does not consent to the project will still
be eligible to take part.
Peer befrienders
Peer befrienders will be people with mild-moderate
aphasia who are over 18 years of age, are at least 1 year
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post-stroke and meet the selection criteria identified by
a group of consultants with aphasia during the develop-
ment phase of this project (see User Involvement). These
comprise good adjustment post-stroke; be open,
confident, resilient and willing to talk with others; able
to concentrate for up to 3–4 h (to travel to and complete
visits); and able to use public transport or to drive. The
Trial Manager who will check eligibility and give initial
information about the project to potential peer befrien-
ders is a highly specialist SLT and will informally assess
befrienders’ aphasia. The Trial Manager will also admin-
ister the short Frenchay Aphasia Screening Test to en-
sure they score a minimum 5/10 for auditory
comprehension and 5/10 for verbal expression.
Exclusion criteria
Participants with aphasia, significant others and befrien-
ders will be excluded from the study if they have the
following:
 Other diagnoses affecting cognition or mental
health, such as, but not restricted to, advanced
Parkinson’s disease, motor neurone disease,
dementia, clinical depression. This will be based on
medical records for participants with aphasia and
self-report for significant others and peer-befrienders,
as well as the General Health Questionnaire 12
(GHQ-12) [32] as a depression screen for peer-
befrienders who will be excluded if they score ≥ 3.
 Severe uncorrected visual or hearing problems,
based on medical records for participants with
aphasia and self-report for significant others and
peer-befrienders.
 Severe or potentially terminal co-morbidities, on
grounds of frailty, based on medical records for
participants with aphasia and self-report for
significant others and peer-befrienders.
People with aphasia will also be excluded if they are
discharged to a geographical location away from the bor-
ough of the recruiting hospital, as this will make it un-
feasible for peer-befrienders to visit those in the
intervention arm.
Recruitment
For those identified in hospital, people with aphasia and
significant others will be screened for eligibility by the
CRN Nurse or the hospital SLT, who will also seek con-
sent for inclusion into the study. The CRN nurse and
the hospital SLT are members of the clinical team and
will know if a patient is eligible /have access to patients’
medical records to assess eligibility. Potential partici-
pants will be approached, given information about the
study, and recruited to the study before the person with
aphasia is discharged from hospital and close to the time
of discharge. For participants who are discharged from
hospital prior to consent being obtained and for those
identified in the community, a community CRN nurse,
community SLT, or a member of the research team will
screen them and obtain consent from those willing to
take part.
For those recruited while still in the hospital, there is a
gap between recruitment to the study and baseline as-
sessment, often 6–8 weeks long while they receive inten-
sive input from an early supported discharge (ESD) team
in their community. Such teams provide intensive (i.e. 3
or more sessions weekly) input from a dedicated
multi-disciplinary team. When a person expresses inter-
est in the study while in hospital but does not meet spe-
cific eligibility criteria that may change after discharge,
i.e. borderline fail (score of 3 on DISCS) on emotional
distress as indicated above, visual or hearing problems
that may be corrected, or temporarily discharged to a
borough away from the recruiting hospital, they will be
asked for their consent to be re-approached for a second
screen in the community. This will ensure we do not
miss participants who do not meet eligibility criteria
when approached in hospital but do meet these criteria
after discharge. The second screen will be organised
within the first 2 weeks of the person’s return to the
community or as soon as possible after that if this is not
feasible.
Training for interacting with people with aphasia will
be provided by the Trial Manager who is a highly spe-
cialist SLT to the CRNs completing consent. The num-
bers of people screened, identified as eligible, and
consented will be recorded at each site and provided to
the Trial Manager at the end of each month. Potential
participants identified in hospital but discharged before
screening will have their details forwarded to the Trial
Manager with their consent and will be screened and
consented into the study by a member of the research
team.
Significant others will be recruited at the same time as
people with aphasia. However, in cases where this is not
possible, recruitment will occur during the initial home
visit.
Nominations for potential peer befrienders will be re-
ceived from recruitment sites (e.g. community SLT, hos-
pital), local services, and voluntary organisations (e.g.
The Stroke Association, Re-Connect). Peer befrienders
will be screened for eligibility and consented into the
study by the Trial Manager.
Ethical issues
The trial will be conducted in compliance with the prin-
ciples of the Declaration of Helsinki (1996), the princi-
ples of Good Clinical Practice (GCP), and in accordance
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with all applicable regulatory requirements including but
not limited to the Research Governance Framework and
the Mental Capacity Act 2005. Ethical approval to con-
duct the study was granted by the NHS Health Research
Authority London-Bloomsbury Research Ethics Com-
mittee (ref 16/LO/2187). Local NHS Research and De-
velopment approvals were also gained from all
participating sites.
Informed consent
Informed consent will be obtained from all participants. The
person obtaining consent will have experience of or receive
training on communicating with people with aphasia using a
total communication approach (e.g. explaining in simple
short sentences, using gestures, pointing to pictures) and
obtaining informed consent. To ensure that each participant
fully understands the nature of the study, participant infor-
mation materials and consent forms were developed that are
accessible to people with aphasia. The materials were devel-
oped following standard aphasia-friendly principles, such as
presenting one idea at a time, using short simple sentences
presented in large font, emboldening keywords, and repre-
senting key ideas with a suitable pictorial image. During the
development phase, we used templates created by the NIHR
CRN for enabling people with aphasia to participate in re-
search [33] and principles from the Consent Support Tool,
which has been specifically designed to facilitate the consent
process with people who have aphasia [34]. Each participant
will have time (up to 48 h) after information is provided to
make an informed decision about whether they would like to
consent to inclusion in the study. Any questions or queries
they may have about the study will be discussed with the
person obtaining consent.
For participants with aphasia, the person obtaining
consent will ask them three simple yes/no or forced al-
ternative questions after information giving, to check
their understanding of key aspects of the study: ‘Is this
study about a drug or how you feel?’, ‘Will our re-
searchers visit you once or many times?’, ‘Can you stop if
you wish, yes or no?’. If participants with aphasia cannot
answer these correctly, this will suggest they have such
severe aphasia that they are unable to give informed
consent and they will not be included in the study. For
participants who are physically unable to sign the form
(e.g. due to weakness in dominant hand due to stroke),
then consent will be given using a mark or line in the
presence of an independent witness (who has no in-
volvement in the trial) who will then corroborate by
signing the consent form.
Two-stage consent process
In behavioural interventions, blinding participants to
treatment versus control allocation is problematic. If
participants are provided with information about the
intervention to be tested, as ethics guidelines require,
they will know whether they are in the intervention or
the control arm of the study. This is particularly prob-
lematic in psychological interventions where people who
may already be distressed or anxious are likely to be-
come even more distressed when they realise they are in
the control arm of a study. Where a participant is aware
that they have been allocated to the control condition,
there are potential threats to validity and maintaining
lack of bias [35, 36]. These threats include the ‘resentful
demoralisation’ effect [37] whereby when participants
are allocated to their non-preferred arm of a trial, it
leads to deflated scores on psychological outcome mea-
sures and/or non-compliance; selective differential attri-
tion rates between groups; and lack of consent to
randomisation from potential participants with strong
preferences over group allocation [35, 36]. Indeed, in
our team’s previous experience with a peer support
intervention with mental health patients at the time of
discharge, many potential participants refused to take
part unless they were guaranteed to receive the peer
support [38]. In such circumstances, some advocate the
use of a Zelen design where only those in the experi-
mental group consent to the trial. An ethical concern
with such a design is that participants are included in a
study without their consent.
To minimise these threats, we are following a modified
two-stage consent design [39, 40], as described in the
Medical Research Council (MRC) framework for com-
plex interventions [41]. This will hopefully encourage re-
cruitment to and retention in the trial while maintaining
participants’ blinding to group allocation. First, we will
invite participants to join a study monitoring progres-
sion and adjustment to life post stroke and aphasia and
comparing different packages of care. Those who con-
sent will be randomised. Those assigned to the control
group will receive usual care; they will know that other
people may receive different care, against which they will
be compared, but they will not know what this entails.
The second stage of consent will involve only those par-
ticipants who have been randomised to peer befriending.
A separate visit (conducted within their own home/com-
munity setting) will be conducted by the Trial Manager
within 1–2 weeks of randomisation to inform partici-
pants of their allocation in the intervention arm of the
trial, give them information about the peer befriending,
and get their consent to participate in this arm. No in-
stances are expected to occur where a participant in the
control arm may need to be unblinded.
Randomisation
Participants will be randomised within three (3) days of
the baseline assessments being completed. For partici-
pants who receive ESD therapies, baseline assessments
Hilari et al. Pilot and Feasibility Studies            (2019) 5:14 Page 5 of 16
will occur once this input is completed. For the rest,
baseline assessments will occur within 1–2 weeks from
discharge home.
King’s Clinical Trials Unit (KCTU) will provide the
randomisation service via their web-based service held
on a secure server in accordance with KCTU standard
operating procedures. On randomisation, a unique pa-
tient identification number (PIN) will be assigned. Each
participant will be randomised 1:1 to usual care + peer
befriending (PEER) or usual care (USUAL). The ran-
domisation allocation will utilise minimisation to pro-
mote balance on important prognostic characteristics,
with a random component to avoid predictability of allo-
cation. Minimisation will be based on the following
characteristics: severity of aphasia (based on WAB
cut-offs, 3 levels), recruitment area (3 levels), and phys-
ical ability (wheelchair user or not).
A CONSORT diagram of recruitment and participa-
tion in the study is shown for people with aphasia (Fig. 1)
and peer befrienders (Fig. 2).
Blinding
The chief investigator, study statisticians, and research
assistants collecting post-baseline quantitative data will
be blinded to treatment allocation until data collection is
complete. To ensure blinding of quantitative outcome
measures, research assistants will not have access to par-
ticipant details, they will follow a script when complet-
ing visits, all visits will be arranged by the Trial
Manager, and participants will be asked to not reveal in-
formation regarding interventions they have received
during assessment. If a research assistant becomes un-
blinded, they will report this to the Trial Manager who
will keep a record of such instances. If this happens dur-
ing the 4-month assessment point, the 10-month assess-
ments will be completed by another research assistant.
Statisticians will receive treatment group with partially
blind coding (i.e. A and B), and data that would unblind
will be stored in a separate database that will not be
accessed by the trial statisticians until the main primary
analysis is done. The Trial Manager, qualitative re-
searchers, health economics researchers, and the
befriender supervisor will be unblinded.
Intervention
Intervention arm—usual care + peer befriending (PEER)
Participants in the intervention arm will receive all usual
care available in their borough and peer befriending.
Peer befriending aims to utilise the skills, knowledge,
and ‘lived experience’ of people with longer-term aphasia
to offer emotional, social, and informational support to
others with aphasia. It aims to help people move forward
and develop their own strategies for adjusting to life
post-stroke. In the trial, peer befriending is offered at a
time of transition (discharge from hospital and with-
drawal of intensive therapeutic input) and increased
need. The intervention is described according to the
TIDieR checklist [28] (see Additional files 2).
Peer-befrienders will receive training based on a
study-adapted version of a peer befriending interven-
tion manual [42] and ongoing supervision and sup-
port. The training will last 5–6 h across 2–3 days to
accommodate the needs of the participants in the
group (e.g. levels of attention and fatigue). The train-
ing will be conducted by two facilitators, who both
have experience of communicating with people with
aphasia. One of the trainers has additional experience
of running peer befriending schemes. The training
will cover a range of topics related to peer befriend-
ing (e.g. the role of a befriender, hopes and fears,
how to have a conversation as a befriender, setting
objectives, identifying barriers, dealing with challen-
ging situations), health and safety, and dealing with
adverse events. Peer befrienders will receive a copy of
a peer befriender handbook, which contains key infor-
mation from the manual in aphasia-accessible format.
It is anticipated that each peer-befriender will work
with 2–4 participants during the trial and no more
than two at any one time.
Peer-befrienders will be offered monthly group super-
vision sessions. These sessions will be conducted by a
single befriender facilitator (also involved in the training)
who is a trained SLT with extensive experience in work-
ing with people with aphasia. The sessions will be an op-
portunity to share experiences and discuss any
difficulties that have arisen. Peer-befrienders who are fa-
cing particular challenges will receive supplementary in-
dividual supervision and support from the same
befriender facilitator. Peer befrienders and the facilitator
will record these challenges. The facilitator will keep de-
tailed written notes to summarise the content of each
supervision session.
Trained peer-befrienders will visit participants in their
own home six times (each visit aimed to be at least 1 h)
over a period of 3 months. A further two visits within
the next 6 months will also be offered for a gradual tran-
sition to the end of the peer befriending. Participants
will be paired with and introduced to their
peer-befriender as soon as possible after and within
1 month of randomisation. If this is not feasible, the rea-
sons for this will be recorded. Where possible, pairing
will take account of preferences around gender, cultural
factors, age, and personal interests. The schedule and
nature of visits will be agreed between the pair at their
first meeting. This meeting will also identify possible
goals for the intervention. For example, participants
might highlight concerns that they would like to discuss
or activities that they would like to pursue. Subsequent
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visits may include conversation, problem-solving, trips
out e.g. to a local group, and joint activities.
After each visit peer-befrienders will complete an
aphasia-friendly record sheet. This will include whether
a visit was cancelled and reason why, length of visit,
topics discussed, activities undertaken, any decisions
made, and date and time of next visit. Peer befrienders
will complete this record sheet immediately or as soon
as possible after each visit if necessary with the help of
the befriender facilitator who will collate these sheets
during monthly supervision sessions. The facilitator will
pass the record sheets on to the Trial Manager on a
monthly basis.
Control arm—usual care (USUAL)
The control group will receive usual care, comprising of
all the health care, social care, and voluntary services
available in their borough. It is not known what exactly
Fig. 1 CONSORT diagram of recruitment and participation for people with aphasia
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usual care comprises for people with aphasia who are
discharged in the community with low levels of psycho-
logical problems. This trial will help to document usual
care by administration of the CSRI questionnaire.
Intervention fidelity
The fidelity of the peer befriender training and supervi-
sion and the peer-befriending intervention will be
evaluated. Fidelity checklists have been created for each
of these three session types to measure how closely they
adhere to the peer befriending intervention manual, the
handbook, and the intended aims of the intervention.
These checklists have been informed by the Health Be-
haviour Change Competency Framework (HBCC) [43]
and rating scales of the interactions of people with apha-
sia and their communication partners [44].
Fig. 2 CONSORT diagram of recruitment and participation for peer befrienders
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All training and supervision sessions will be video-
taped. All training sessions and all supervision sessions,
except the first and the last, will be watched by un-
blinded team researchers and research students and
rated against the fidelity checklists to ensure training
and supervision are delivered as intended. With partici-
pants’ consent, a proportion of befriending visits (1 per
participant) will also be videotaped and watched against
a fidelity checklist. Results from these checks will be re-
ported back to the befriender facilitator to inform later
content of the supervision sessions.
Information from the supervision notes and from the
peer befriender visit record forms will also be used to
evaluate whether peer befrienders followed the peer
befriending handbook and to compare content of inter-
vention between and within different peer befrienders.
This information will provide additional qualitative in-
formation and context on the fidelity of the intervention.
Procedures
Outcome measures data will be collected by blinded re-
search assistants/assessors who are trained and skilled in
communicating with people with aphasia. Assessors will
be given a data collection pack for each participant, at
each time point. These packs will contain a script to
guide their conversations with participants and verbal
instructions for each of the outcomes administered. Dur-
ing the development phase of the trial, an example as-
sessment session was videotaped between a member of
the research team and a person with aphasia (consultant
with aphasia, see User and public involvement). This
training video will be used to ensure consistent adminis-
tration of the outcome measures. In addition, the Trial
Manager will observe the first videotaped assessment
session of each assessor. Further assessment sessions will
be observed at random by the Trial Manager either in
person or by reviewing videotaped sessions.
The qualitative research assistant conducting the
semi-structured interviews will similarly be supported.
They will receive training in conducting semi-structured
interviews from a senior qualitative researcher in the
team, who has extensive experience of adapting qualita-
tive methodologies for people with aphasia. The senior
qualitative researcher will listen to two audiotaped initial
interviews and give feedback, for example, to ensure
questioning is unbiased and leads to the full exploration
of topics. They will continue to support the qualitative
research assistant throughout the trial and will periodic-
ally listen to interviews.
For the economic evaluation, either the Trial Manager
or the qualitative research assistant will collect informa-
tion using a stroke adapted version of the Client Service
Receipt Inventory (CSRI) [45]. They will be given train-
ing in completion of the CSRI and eliciting resource use
information by a member of the study team with rele-
vant health economics expertise. As much information
as possible will be collected from the significant other as
primary respondent, where available. The Trial Manager
will draw additional information by contacting CRN
nurses or members of the clinical team as appropriate.
To facilitate participants to attend baseline and
follow-up sessions, participants, significant others and
peer befrienders will be contacted by text/telephone at
least 1 week prior to each assessment session and on the
previous day to confirm appointment times. To maxi-
mise retention and participant engagement in the pro-
ject, a quarterly newsletter will be sent out, and a single
phone-call between follow-up assessment times will also
be made to remind them of their next appointment.
Measures
At baseline, all participants will complete a case history
covering: demographic and health information, family
and social circumstances, and personal interests. This in-
formation will be used to report on participant charac-
teristics and will also contribute to pairing with peer
befrienders for those in the intervention arm. For partic-
ipants with aphasia, aphasia will be fully assessed with
the Western Aphasia Battery-Revised [46], and cognition
with the Cognitive-Linguistic Quick Test (CLQT) [47],
which has been specifically developed for people with
aphasia. These assessments will be reported descriptively
under participant characteristics.
Feasibility outcomes
Feasibility outcomes will include the following:
 Proportion of participants with aphasia who are
eligible of those screened
 Proportion eligible at first screen
 Proportion eligible at second screen
 The rate of eligibility per month
 Proportion who consent of those eligible
 The rate of consent per month
 The rate of recruitment (participants randomised)
per month
 The frequency and proportion of people consented
who withdraw overall, by study arm, and by those
who do before and after randomisation. This will
specifically include describing those in the PEER
arm who decline consent at the second stage
 Acceptability of research procedures and outcome
measures based on qualitative interviews
 Acceptability of the intervention and also usual care
to participants, their significant others, and peer
befrienders, based on qualitative interviews
 Documentation of usual care, based on data from
CSRI
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 Fidelity and adherence, based on session
observations, visit record sheets, and supervision
records.
Moreover, we will informally ask CRN nurses and
other members of the clinical teams involved with SU-
PERB in all our sites about their experiences with the
trial. This information will provide additional context to
our feasibility outcomes.
Patient-reported outcome measures
A range of outcome measures will be used with partici-
pants with aphasia covering mood, wellbeing, activities,
and communication and social participation. Measures
chosen have either been developed specifically for
neurologically impaired populations, some including
people with aphasia or have been previously used with
people with aphasia with good evidence of accessibility
and acceptability. Where appropriate, the presentation
of measures will be modified to make them
aphasia-friendly in line with best practice guidelines
[48]. The content, however, will not be changed to avoid
affecting measures’ psychometric properties.
The following primary outcomes for participants with
aphasia will be completed at baseline, 4 and 10months
post-randomisation: General Health Questionnaire-12
(GHQ-12) [32], using 0 0 1 1 scoring and the Depression
Intensity Scale Circles (DISCS) [30]. The DISCS is being
measured because some participants may not be able to
complete the GHQ-12. This feasibility study will assess
how often this is the case. The DISCS will be treated as
the primary outcome measure only if there is ≥ 10%
missing data in the GHQ-12 due to severity of aphasia;
otherwise, DISCS will be a secondary outcome measure.
The following secondary outcomes for participants
with aphasia will be taken at the same time points: Short
Warwick Edinburgh Mental Well-being Scale-7 [49],
Communicative Participation Item Bank [50], Commu-
nity Integration Questionnaire—Adapted [51]. Propor-
tion with high emotional distress vs low emotional
distress as measured using the GHQ-12 (high distress =
score of 3 or more, low distress = score of 0–2). There
are additional psychological constructs that may be af-
fected by peer befriending; however, the evidence base is
not strong on whether existing measures on these con-
structs are responsive to change when used with people
with aphasia. We will include two exploratory self-report
outcomes for participants with aphasia in this study, the
Communication Confidence Rating Scale for people with
aphasia [52, 53] and the Friendship Scale [54] in order
to see whether they may be suitable to use as secondary
outcome measures in a definitive trial. These will be
completed by participants with aphasia at each of the
three time points.
The following outcomes for significant others will be
taken at baseline, 4 and 10 months post-randomisation:
Warwick Edinburgh Mental Well-being Scale [55]; Gen-
eral Health Questionnaire-28 (GHQ-28) [32], with 0 0 1
1 scoring and descriptive information on its four sub-
scale scores; and Bakas Caregiving Outcome Scale [56].
Outcomes for peer befrienders will be taken at base-
line and on completion of two befriending cycles, i.e. six
befriending visits with each of two participants. For
befrienders who do not fully complete a cycle because,
e.g. the participant with aphasia dies or withdraws, the
cycle will be considered completed if they have done a
minimum of two visits. Outcomes comprise the War-
wick Edinburgh Mental Well-being Scale-7; Community
Integration Questionnaire—Adapted; and General
Self-Efficacy Scale [57].
Qualitative outcomes
Interviews will be conducted with ten participants with
aphasia in each arm of the trial at 4 months
post-randomisation. These interviews will explore partici-
pants’ experience of taking part in the study and also what
has helped participants in adjusting to living with stroke
and aphasia. They will probe what participants have found
useful in terms of emotional well-being, confidence, and
thoughts about the future. The interviews will also explore
participant experiences of services they have received in
terms of their psychological well-being post stroke. Those
who received peer befriending will also be asked about their
experiences of the intervention, its perceived benefits, and
any difficulties. The subset of participants interviewed from
the PEER arm of the trial will be re-interviewed at
10 months about the longer term impact of the stroke and
aphasia and their perceptions about the intervention.
A sub-sample of five significant others from each arm
will be interviewed at 4 months to explore the impact of
the stroke and aphasia on their life and family life and
their perspectives of the care received. Those in the
PEER arm will also be asked about the administration
and impact of peer befriending. All interviewed partici-
pants will be selected purposively to capture a diversity
of views. Key sampling criteria for participants with
aphasia are severity of aphasia and whether the person
lives alone. Secondary criteria are geographical area,
gender, mobility, GHQ-12 score, and ethnicity. For sig-
nificant others, sampling criteria include relationship to
person with aphasia (partner/spouse or child/other), eth-
nicity, gender, and GHQ-28 scores.
All befrienders will be interviewed after they have
completed two cycles of befriending (minimum two
visits per cycle) to explore their experience of the study,
including reflections on programme training and deliv-
ery, support received, any concerns or difficulties, and
perceived benefits of peer befriending.
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Economic evaluation
The European Quality of Life measures, 5 dimensions, 5
levels (EQ-5D-5L) [58] will be collected for participants
with aphasia at baseline, 4 and 10 months post-random-
isation, and the Stroke-adapted CSRI at 4 and 10months
post-randomisation.
Sample size
We will recruit in total 60 participants with aphasia (30
in each arm of the study). Allowing for a ~ 15% lost to
follow-up rate, at least 50 will complete the study. With
60 participants recruited, we will be able to estimate a
95% confidence interval for the recruitment rate to
within approximately 25%. This sample size will be ad-
equate to estimate important parameters needed to in-
form the design and the sample size of a full trial, such
as the standard deviation, consent rates, event rates.
This sample size also meets recommended sample sizes
for feasibility studies [59].
Although this is a feasibility study, we would like to es-
timate exploratory differences between the PEER and
USUAL arms. If we assume we retain 50 participants at
follow-up, a two-sided test, α = 0.05, and independence
of participants, we will have 80% power to detect an ef-
fect size of approximately 0.8. The standard deviation of
the primary GHQ-12 outcome in a generic population
of patients with stroke has been shown to be approxi-
mately 3.6—this was using the 0 0 1 1 scoring, with total
scores ranging from 0 to 12 [60]. This effect size corre-
sponds to an approximate mean difference of 3 points
between groups. This sample size is sufficient for these
exploratory comparisons; however, in a definitive trial,
we would want to have higher power to detect a smaller
effect size. This feasibility study will give us a standard
deviation specific to the group that we would be inter-
ested in recruiting for a definitive trial, so would help to
inform such a sample size calculation.
Statistical methods: data analysis
Feasibility outcomes
As SUPERB is a feasibility trial, the feasibility outcomes
are the most important/will take precedence. We will
calculate proportion who are eligible of those screened
(number eligible/number screened), proportion who are
eligible at first screen (number eligible/number screened
at first screen) and second screen (number eligible/num-
ber screened at second screen), rate of eligibility per
month, proportion who consent of those eligible (num-
ber who consent/number eligible), rate of consent per
month, and rate of recruitment (participants rando-
mised) per month. The frequency and proportion of
people consented who withdraw overall, by study arm,
and by those who do before and after randomisation will
be presented. This will specifically include describing
those in the PEER arm who decline consent at the sec-
ond stage. Appropriate 95% confidence intervals will be
constructed for all of the above measures.
Descriptive statistics
Trial flow data will be reported as outlined by the CON-
SORT statement. We will use descriptive statistics to
document what usual care consists of, based on data
from the CSRI. The primary and secondary outcomes
will be summarised using summary statistics, for the en-
tire trial population and by trial arm, at each trial time
point. The primary and main secondary outcome means
and confidence intervals will be plotted over time. These
summary statistics will help inform sample size estima-
tion for the definitive trial.
Outcome measures’ analyses
Despite the feasibility nature of the trial, we will com-
pare the PEER and USUAL groups. These will be con-
sidered strictly exploratory. For primary outcome
analysis, the comparison will be between the PEER and
USUAL groups. The GHQ-12 will be scored 0 0 1 1 and
summed, resulting in a 0–12 score range. This overall
total GHQ-12 score will be analysed using linear mixed
models with the 4 and 10 months post-randomisation
measures as dependent variables, with a random inter-
cept for individuals, and time, the baseline GHQ-12
score, a dummy variable indicating treatment group, the
minimisation stratification factors, and any baseline vari-
ables that were imbalanced or that predicted missingness
as independent variables to improve the plausibility of
the missing at random assumption. A treatment group
by time interaction term will be included to allow for
extracting comparisons at the 4- and 10-month
post-randomisation time points. These models will ac-
count for missing data using the maximum likelihood
algorithm.
In addition, if at least some peer befrienders see mul-
tiple participants (e.g. > 2), we will explore the possibility
of calculating the GHQ-12 intra-class correlation coeffi-
cient (ICC) by fitting a linear mixed effects model using
the data from the PEER group with the 4 and 10months
post-randomisation measures as dependent variables
and a random intercept for befriender to calculate the
within-peer, between-peer, and total variability for clus-
ters of participants seen by the same peer befriender.
This ICC will help inform a sample size calculation for a
larger trial and provide estimates of a peer befriender
ICC to publish in the literature. If the DISCS is used as
the main primary outcome instead of GHQ-12, it will be
analysed in a similar manner.
The significant other outcomes and the secondary and
exploratory participant with aphasia outcomes will be
analysed in a similar manner to the primary outcome,
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comparing the outcomes between the PEER and USUAL
groups. The peer befriender outcomes will be compared
between the baseline and post-befriending time points
using a paired t-test.
All analyses will initially be conducted on an
intention-to-treat basis. A second per protocol analysis
will be done on the primary and secondary outcomes,
excluding participants who are not in compliance with
the protocol. Participants deemed not compliant will in-
clude those who did not consent at the second stage,
completed less than six peer befriending sessions, were
found to be ineligible after randomisation based on the
inclusion/exclusion criteria, and participants in the usual
care group who received peer befriending outside the
study as reported to assessors or measured using the
CSRI (in addition to their removal, we may explore ana-
lysing them in the peer group).
Missing data
The amount and reasons for missing data will be sum-
marised overall and by treatment group. Missing data
will be accounted for where mixed models are applied
under the missing at random assumption using the max-
imum likelihood algorithm. The baseline characteristics
of those missing follow-up and those with complete
follow-up will be summarised and variables affecting
missingness will be examined using a logistic predictor
of missingness model. This will be done by generating a
binary variable for missingness for the primary outcome
variable 10 months post-randomisation (we will explore
the need to do this either separately or combined for the
primary and secondary outcomes) and regressing this on
baseline variables. Any variables found to be important
predictors of missingness will be included in the primary
and secondary outcome models. From a health eco-
nomic perspective, where there is missing data, we will
analyse the data on a complete case analysis basis and
additionally use mean imputation for missing values.
This will allow for a sensitivity analysis indicating
whether missing values could be biasing the data.
Qualitative analysis
All qualitative data will be analysed using Framework
Analysis [61]. Initial themes and concepts will be identi-
fied through reviewing the data. These will then be used
to construct a thematic index, used to assign a label to
each phrase or passage. The labelled raw data will then
be summarised and synthesised into the thematic charts.
This matrix-based method of analysis will facilitate sys-
tematic exploration of the range of views including both
between cases and within cases in order to produce both
descriptive and explanatory accounts of the data. To min-
imise potential bias, a second analyst will independently
index a proportion of transcripts and analyse the
matrix-based material.
Economic evaluation analysis
This pilot economic evaluation study has the objective
of detecting problems in the cost collection, exploring
how patients respond to the primary outcome in the
study, the GHQ-12, and comparing it to the EQ-5D-5 L
instrument, as well as developing the economic evalu-
ation model that will be applied to a phase III RCT. The
pilot economic evaluation will compare incremental
costs to incremental health gains of the PEER arm ver-
sus USUAL arm. Due to the very low numbers, this will
be strictly an exercise to detect problems in the process
of data collection and development of the full economic
evaluation model. The rationale is to use the feasibility
stage data to prepare a future full trial cost-effectiveness.
For the costs, we will use data collected on the CSRI
on service use (including health, social, and voluntary
services) and associated costs at 4 and 10months
post-randomisation. Unit costs of resources used will be
derived from routine sources locally where possible and
from national sources such as the NHS reference costs.
Health gains will be obtained from the answers to both
the GHQ-12 and to the EQ-5D-5 L instruments. The
gold standard for economic evaluation is to use generic
health state outcome measurements because these allow
comparability across clinical areas. Thus, we will run
two types of pilot economic evaluation analyses. First,
we will run a pilot cost-effectiveness analysis based on
the GHQ-12. Second, we will perform a pilot cost-utility
analysis using quality-adjusted life years (QALYs) gained
based on the answers to the EQ-5D-5 L. Additionally,
since there is limited evidence on how the GHQ-12 and
EQ-5D-5 L relate to each other [38], we will use the pilot
data to explore the correlation of these two instruments
in terms of health gains in different domains.
With the pilot cost and outcome data, we will explore
the calculation of confidence intervals for costs and
health gains using non-parametric bootstrapping, with
the understanding that low numbers preclude generalis-
ability. Also, we will explore the application of probabil-
istic sensitivity analysis that will eventually generate
cost-effectiveness acceptability curves in a Phase III
RCT. These curves graphically represent provisional es-
timates of the cost-effectiveness of the intervention.
Fidelity
Videotaped sessions will be rated against fidelity check-
lists. Fidelity of the peer befriending training and super-
vision to the training manual and the peer befriending
intervention to the peer befriending handbook will be
evaluated by calculating a per cent fidelity score
(components implemented/components planned × 100).
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Inter-rater (two raters) and intra-rater reliability will be
calculated for all three session types. Inter-rater agree-
ment coefficients will be used to calculate inter and
intra-rater reliability. Counts of sessions completed will
indicate whether befriender/befriendee pairs have ad-
hered to the six befriending visits.
Data management
The main trial database will be hosted at King’s Clinical
Trials Unit (KCTU). Data will be managed using the
InferMed MACRO database system. This system is regu-
latory compliant (GCP, 21CRF11, EC Clinical Trial Dir-
ective). Data will be entered by authorised staff (Trial
Manager and research assistants) with a full audit trail in
which participants will be identified by their unique PIN.
The database will include feasibility data on people con-
sented, with these data being aggregated where we do
not have consent to hold participants’ data (for example,
reasons for declining participation), as well as assess-
ment and outcome measures data, and serious adverse
event data.
A separate database storing intervention details will also
be hosted at KCTU. This will include all necessary infor-
mation on the intervention each participant in the PEER
arm received as extracted by visit record forms and infor-
mation from supervision sessions (e.g. number of sessions
arranged, completed, missed and reason why; duration of
session; topics discussed). The intervention database will
meet the same requirements as the main trial database
above, but only the Trial Manager will be authorised to in-
put data and have access. Trial statisticians will only have
access after unblinding. Data in the second database will
be extracted and summarised routinely by an unblinded
statistician independent to the trial when necessary.
Fidelity data, qualitative data, and health economic data
will be kept at City, University of London, on a secure net-
work drive within the City system, which is regularly backed
up. The fidelity dataset will be anonymised with participants
being identified by their PIN. The Trial Manager and un-
blinded researchers analysing fidelity data will have access to
it. Qualitative data will be transcribed and then saved by the
qualitative research assistant in an electronic database. Par-
ticipants in the qualitative data database will be identified by
their unique PIN; however, this database will also include
identifying information, such as gender and age. Health eco-
nomic data will be entered onto a password-protected Excel
spreadsheet. Each participant on this spreadsheet will be
identified by their PIN. Qualitative and health economics
data will be accessible by the Trial Manager and qualitative
and health economics researchers.
Site monitoring
The Trial Manager will conduct on-site/central monitor-
ing. The Trial Manager will do monthly checks on data
completeness and range checks as outlined in the data
management plan. In addition, regular checks of a se-
lected number of participant records will be done at
three monthly intervals to check that data recording
procedures are being followed consistently and accur-
ately. The data will also be perused by the trial statisti-
cian when extracted for Data Management Committee
reports and at the end of the study. Data queries will be
raised by the trial statistician and sent to the Trial Man-
ager for resolution. Any issues found in any of these
checks will be resolved against the original source re-
cords and corrected in the MACRO database where
possible.
Anticipated risks and benefits
The risk of harm is considered unlikely to participants
and low risk, which was further confirmed by early user
consultation. Research assistants and peer befrienders
visiting participants with aphasia will have a Disclosure
and Barring Service (DBS) check, to ensure participant
safety. There are no formal statistical criteria for stop-
ping the trial early. Decisions to stop the trial early on
grounds of safety or futility (with regard to recruitment)
will be made by the Trial Steering Committee on the
basis of advice from the Data Management Committee.
Some participants may experience fatigue and poor
concentration during assessment sessions. To minimise
this, information will be provided in an accessible
aphasia-friendly way and researchers will offer breaks as
and when needed. It will also be made clear to partici-
pants that they can request a break at any time or add-
itional visits to complete outcomes.
There is the risk that participants may become bur-
dened with their involvement in the study. Participants
may get upset during assessment and/or outcome meas-
urement, or peer befriending visits. All researchers and
peer befrienders will be trained and supervised to deal
with these situations, for example they may take a break,
see if the participant wants to talk about their feelings,
or stop the session if needed. Issues raised by peer
befrienders will be discussed in monthly supervision
with the befriender facilitator, with additional individual
support provided as needed. If a participant or peer
befriender scores within the high emotional distress
range of the GHQ-12 (3 or more) or the GHQ-28 for
significant others (6 or more), the research assistant or
Trial Manager will discuss with them their score and ask
them to consider talking to their GP. If they would like,
they will be given information on local support organisa-
tions and groups. For peer befrienders who score within
the high emotional distress range of the GHQ-12, the
Trial Manager will explore with them whether they find
peer befriending distressing and whether they need to be
withdrawn from the study.
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In terms of benefits, participants in this study will re-
ceive all their usual care; no treatment will be withdrawn
due to participation in the study. Information about
local support services and voluntary organisations that
support well-being post-stroke will be offered to those
experiencing low mood and it will also be offered if par-
ticipants express feelings of loneliness and social isola-
tion. Trained befrienders will also be linked to local
support organisations, where their skills can be used in
the future to support people with aphasia.
User and public involvement
People with aphasia are engaged at every stage of the
SUPERB trial, and the trial cannot run without their in-
volvement. While developing the proposal for this study,
we held a consultation event with six people with apha-
sia, where they reviewed and influenced our plans for
the study. Prior to the commencement of recruitment,
we had a 6-month development phase, where six consul-
tants with aphasia with extensive experience in deliver-
ing peer befriending advised on key decisions through a
series of six 3-h workshops. These decisions included:
the criteria for a peer befriender, choice of outcome
measures, design of information sheets and consent
forms, content of peer befriending training manual and
handbook, and questions to ask during qualitative inter-
views. During the trial, we will train and employ people
with aphasia as peer befrienders, i.e. they will deliver the
intervention tested in this study. In our evaluation, apart
from feasibility and patient-reported outcomes, we will
elicit the views of participants with aphasia, their signifi-
cant others, and peer befrienders on the intervention
and study processes in qualitative interviews. Lastly, a
user group comprising at least four people with aphasia
and one significant other will advise on the study. The
user group will meet five times during the course of the
trial and will advise on management issues, the implica-
tions of the findings, and dissemination to the stroke
community.
Trial management
Three committees have been established to govern the
conduct of the study: the Trial Management Committee,
the Trial Steering Committee (TSC), and the Data Man-
agement Committee (DMC). The Trial Management
Committee will comprise the Chief Investigator and
Co-investigators, the Trial Manager, and junior statisti-
cian and will meet monthly to manage the project. The
Trial Management Committee will sign off the protocol
and agree to all standard operating procedures before
the start of recruitment. The committee will also provide
overall supervision of the trial including trial progress,
adherence to protocol, patient safety, and consideration
of new information. The committee forms a strong
multidisciplinary team who will report to the TSC.
The TSC will consist of an independent chair and in-
dependent and non-independent members, as well as
the Trial Manager and key partners from our recruiting
sites. This group will meet six times during the project
to oversee the study management. They will also be
consulted via email as and when needed. They will be
responsible for reviewing and approving trial documen-
tation (e.g. protocol, information sheets, and consent
forms) and oversee the conduct of the study, including
advising on continuing or stopping the study in light of
advice from the DMC. This committee will advise on
processes (e.g. fidelity checking; monitoring and report-
ing adverse events) and issues (e.g. recruitment to target;
site-specific issues) as they arise.
The DMC will consist of an independent from the
study chair; an independent specialist with interest in
trials for people with stroke and aphasia; and an inde-
pendent statistician. This committee will meet four
times to approve the data management plan, monitor
adverse events, and monitor the progress of the trial in
relation to safety and ethical issues, including recruit-
ment, uptake of the intervention, withdrawal from the
trial, descriptive summaries of the outcomes and any
other variables they feel are critical to trial monitoring.
They will meet again on completion of data collection.
The DMC and the trial statistician will discuss the level
of access to unblinded data and will include this level of
access and any procedures for unblinding the DMC in
the DAMOCLES charter that will be agreed at the first
meeting. The DMC will report to the TSC and may ad-
vise the TSC to continue or to stop the trial should they
feel this is necessary based on their monitoring of the
data.
Discussion
This exploratory (phase II) RCT will evaluate the feasi-
bility of a phase III RCT on the clinical and
cost-effectiveness of peer befriending for people with
aphasia post-stroke. Effect sizes with 95% confidence in-
tervals will be estimated to check that the likely effect is
within a clinically relevant range as confirmation that it
is worth planning a definitive trial. This information to-
gether with acceptability of the study data, safety of
intervention, participant recruitment, and retention rates
will help us determine whether the definitive RCT is
feasible and whether modifications are needed to the
intervention and/or the protocol. As multiple outcomes
are considered in this study, including qualitative data,
we have not set specific targets for the feasibility out-
comes. According to the CONSORT 2010 extension
statement for pilot and feasibility trials, even when such
targets are set, they may be best viewed as guidelines
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rather than thresholds for progression [62]. As recom-
mended in the CONSORT 2010 extension statement, we
will consult with key stakeholders, including our TSC
and user advisory group, when considering whether to
progress to a definitive trial and potential amendments
to the protocol. We will draw on the ADePT model (A
process for Decision-making after Pilot and feasibility
Trials) [63] to explore the best pathway forward from
this feasibility study. The ADePT model provides a
framework which enables (1) systematic identification
and appraisal of problems and potential solutions/
amendments, (2) increased transparency in the
decision-making process, and (3) a process to make clear
any tensions which may exist between explanatory and
pragmatic choices (i.e. potential solutions which may
work well within the trial, but less well in the real
world).
This paper reports protocol version 5 (4 July 2018).
Ethical approval for the SUPERB trial was obtained on
31 January 2017. Approvals from all sites to begin re-
cruitment were completed by 6th April 2017. Recruit-
ment, in terms of identification of potential participants,
was completed on 31st August 2018, with the last par-
ticipant consented to the study 9th October 2018.
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